These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation. Dresske B; Zavazava N; Jenisch S; Exner B; Lenz P; El Mokhtari NE; Kremer B; Faendrich F Transplantation; 2003 Apr; 75(8):1286-91. PubMed ID: 12717217 [TBL] [Abstract][Full Text] [Related]
29. De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results. Meiser B; Buchholz S; Kaczmarek I Curr Opin Organ Transplant; 2011 Oct; 16(5):522-8. PubMed ID: 21836511 [TBL] [Abstract][Full Text] [Related]
30. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation]. Zhu L; Ding T; Wang XX; Lin ZB; Chen G Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681 [TBL] [Abstract][Full Text] [Related]
32. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. Troppmann C; Pierce JL; Gandhi MM; Gallay BJ; McVicar JP; Perez RV Transplantation; 2003 Jul; 76(2):426-9. PubMed ID: 12883205 [TBL] [Abstract][Full Text] [Related]
33. mTOR inhibitor monotherapy. A good treatment choice in renal transplantation? Franco-Esteve A; Tordera D; de la Sen ML; Jiménez L; Mas P; Muñoz C; Olivares J Nefrologia; 2012; 32(5):631-8. PubMed ID: 23013949 [TBL] [Abstract][Full Text] [Related]
34. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Shapiro R; Jordan ML; Basu A; Scantlebury V; Potdar S; Tan HP; Gray EA; Randhawa PS; Murase N; Zeevi A; Demetris AJ; Woodward J; Marcos A; Fung JJ; Starzl TE Ann Surg; 2003 Oct; 238(4):520-5; discussion 525-7. PubMed ID: 14530723 [TBL] [Abstract][Full Text] [Related]
35. Outcome predictors in African-American deceased-donor renal allograft recipients. Brown KL; El-Amm JM; Doshi MD; Singh A; Cincotta E; Morawski K; Losanoff JE; West MS; Gruber SA Clin Transplant; 2009; 23(4):454-61. PubMed ID: 19191806 [TBL] [Abstract][Full Text] [Related]
36. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology. Stevens RB; Foster KW; Miles CD; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Malik T; Wrenshall LE PLoS One; 2015; 10(10):e0139247. PubMed ID: 26465152 [TBL] [Abstract][Full Text] [Related]
37. Kidney transplantation with corticosteroid-free maintenance immunosuppression: a single center analysis of graft and patient survivals. Filipe R; Mota A; Alves R; Bastos C; Macário F; Figueiredo A; Roseiro A; Parada B; Sá H; Nunes P; Bastos M Transplant Proc; 2009 Apr; 41(3):843-5. PubMed ID: 19376367 [TBL] [Abstract][Full Text] [Related]
38. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression. Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704 [TBL] [Abstract][Full Text] [Related]